CME: More Chemo May Not Equal Better Outcomes in Ovarian early stage (clear cell) Cancer

Medpage Today

Action Points

• Recurrence and survival in patients with early stage ovarian clear cell carcinoma (OCCC) were similar in those receiving 3 versus 6 cycles of platinum with or without taxane adjuvant chemotherapy, in a retrospective multi-institutional cohort.
• Note that the study was statistically underpowered and further clinical trials, including the use of novel agents, are needed to better illuminate the best strategy for treating early stage OCCC.

abstract
 Three versus six cycles of adjuvant platinum-based chemotherapy in early stage clear cell ovarian carcinoma – A multi-institutional cohort 
Published online: December 12, 2016